INNOSPEC INC. (IOSP)
INNOSPEC INC. (IOSP) from its SEC filings: 2025 revenue $1.8 billion (-4% vs the year before), free cash flow $138.3 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Chemicals & Allied Products |
| Revenue (2025) | $1.8 billion |
| Revenue growth | -4% |
| Free cash flow | $138.3 million |
| Diluted EPS | $4.67 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +12% |
| Cash | $250.2 million |
| Long-term debt | $0 |
| Share count, 1 year | -1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.